Ardent Health Partners (NYSE:ARDT) Earns Overweight Rating from Stephens

Ardent Health Partners (NYSE:ARDT)‘s stock had its “overweight” rating restated by Stephens in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $22.00 target price on the stock. Stephens’ price objective would indicate a potential upside of 67.26% from the stock’s previous close.

A number of other research analysts also recently commented on the stock. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $20.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Royal Bank of Canada cut their price target on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 4th. Morgan Stanley lowered their price objective on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a research note on Tuesday, January 21st. Finally, Truist Financial cut their target price on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Ardent Health Partners has a consensus rating of “Buy” and a consensus price target of $21.18.

Ardent Health Partners Stock Performance

NYSE:ARDT opened at $13.15 on Wednesday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The firm has a 50 day simple moving average of $14.43 and a 200-day simple moving average of $16.28. Ardent Health Partners has a 1-year low of $12.87 and a 1-year high of $20.72.

Ardent Health Partners (NYSE:ARDT) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.31. The business had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.48 billion. On average, equities research analysts anticipate that Ardent Health Partners will post 1.23 earnings per share for the current year.

Institutional Investors Weigh In On Ardent Health Partners

A number of large investors have recently modified their holdings of the stock. Point72 Asia Singapore Pte. Ltd. purchased a new position in Ardent Health Partners in the 4th quarter worth approximately $27,000. US Bancorp DE purchased a new position in shares of Ardent Health Partners in the fourth quarter valued at $31,000. R Squared Ltd acquired a new stake in Ardent Health Partners during the 4th quarter valued at $37,000. BNP Paribas Financial Markets purchased a new stake in Ardent Health Partners during the 3rd quarter worth $42,000. Finally, New York State Common Retirement Fund acquired a new position in Ardent Health Partners in the 4th quarter worth $48,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.